Kidney Cancer: What Newly Diagnosed Patients and Survivors Need to Know. Kidney cancer—most commonly renal cell carcinoma (RCC)—is one of the more challenging solid tumors because it is often silent in early stages and frequently discovered incidentally during imaging.
If you’ve been diagnosed with kidney cancer or you are a survivor trying to reduce your risk of recurrence, this guide walks you through the essential facts, evidence-based therapies, and practical steps you can take.
If you or someone you love has been diagnosed with kidney cancer, understanding the disease, treatment options, and supportive therapies can help you make informed decisions and improve outcomes.
This post explains the essentials of kidney cancer and highlights evidence-based integrative therapies that may improve treatment tolerance, immune function, and survivorship.
Consider these evidence-based, non-conventional therapies-
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining the quality of life of the cancer patient. Consider therapies shown to reduce possible side effects.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about breast cancer.
Good luck,
Kidney cancer begins when abnormal cells grow uncontrollably in the kidney, most often in the lining of tiny filtering tubes.
Kidney cancer is often called a “silent disease” because:
Survival depends heavily on stage at diagnosis:
👉 This makes early detection and long-term survivorship strategies critical.
These are among the strongest preventable contributors to kidney cancer
👉 The takeaway: lifestyle changes matter more than many patients realize.
Treatment depends on stage, tumor size, and overall health.
Small tumors (<4 cm) treated surgically can have >94% cancer-specific survival
Used for advanced or metastatic disease:
These therapies have significantly improved survival since ~2005
For small, slow-growing tumors:
While conventional treatment is essential, non-toxic, evidence-based therapies can support outcomes and survivorship.
👉 Focus on:
Because hypertension and CKD are linked to kidney cancer:
While not kidney-cancer-specific in all cases, research supports:
Kidney cancer is one of the most immunotherapy-responsive cancers, which is why immunotherapy works.
Lifestyle strategies that support immunity:
Kidney cancer can recur years after treatment.
Key predictors of recurrence:
👉 Smaller tumors (≤4 cm) have significantly better prognosis
These target the same biological pathways that drive kidney cancer development.
If you are dealing with kidney cancer:
Kidney cancer is not just a surgical disease—it’s a metabolic, inflammatory, and immune-related disease.
The more you address all three dimensions, the better your odds—not just of survival, but of long-term health
kidney cancer: need to know kidney cancer: need to know kidney cancer: need to know